Alexion Pharmaceuticals, Inc. (ALXN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Alexion Pharmaceuticals, Inc. (ALXN)

ALXN 182.50

0.0%

Jul 28 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Icebrg who wrote (306)	8/7/2003 12:25:02 PM
From: keokalani'nui	Read Replies (2) of 824

Why bother if < 6mos? Personally I would want the FDA bother to approve a drug that would allow (1) an additional 30 days of life or (2) an additional 30 days without a major infarct--even if death were to come 6 months later at home. That's 30 days for sure, probably up to 90, likely up to 180, and possibly longer...all for $1000 or a mere $33 per day (30 days). Apparently 0 side effects. Look at the cancer market for heavens sake, drugs costing ten thousand dollars are approved based on 2 months survival and in a population whose death is largely prepared for. Wilder

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next